Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Free Cash Flow (2024 - 2025)

Carlsmed's Free Cash Flow history spans 2 years, with the latest figure at -$5.5 million for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 33.86% year-over-year to -$5.5 million; the TTM value through Dec 2025 reached -$18.2 million, changed N/A, while the annual FY2025 figure was -$29.7 million, 16.59% down from the prior year.
  • Free Cash Flow reached -$5.5 million in Q4 2025 per CARL's latest filing, up from -$8.7 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$4.1 million in Q4 2024 to a low of -$8.7 million in Q3 2025.